Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 15 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-27 4 AS $48.34 $193,360 D/D (4,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-27 4 OE $12.99 $51,960 D/D 4,000 184,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-23 4 AS $55.22 $220,880 D/D (4,000) 153,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-02-06 4 OE $12.99 $51,960 I/I 4,000 54,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-11-10 4 S $87.00 $348,000 I/I (4,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-11-10 4 OE $12.99 $51,960 I/I 4,000 47,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-29 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-29 4 AS $83.84 $335,360 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-30 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-30 4 AS $83.35 $333,400 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-06 4 AS $87.19 $348,760 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-06 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-09 4 AS $89.79 $359,160 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-09 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-10 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-10 4 AS $91.31 $365,240 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-11 4 AS $89.84 $359,360 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-11 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-01 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-01 4 AS $92.55 $370,200 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-26 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-26 4 AS $80.50 $322,000 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-14 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-14 4 AS $93.79 $375,160 D/D (4,000) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-05 4 OE $14.39 $57,560 D/D 4,000 292,290 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15  16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 15 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us